Gene: PIGP
Official Full Name: phosphatidylinositol glycan anchor biosynthesis class Pprovided by HGNC
Gene Summary: This gene encodes an enzyme involved in the first step of glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells that serves to anchor proteins to the cell surface. The encoded protein is a component of the GPI-N-acetylglucosaminyltransferase complex that catalyzes the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). This gene is located in the Down Syndrome critical region on chromosome 21 and is a candidate for the pathogenesis of Down syndrome. This gene has multiple pseudogenes and is a member of the phosphatidylinositol glycan anchor biosynthesis gene family. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Feb 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22846 | PIGP Knockout cell line (HeLa) | Human | PIGP | 1:3~1:6 | Negative | Online Inquiry |
KO22847 | PIGP Knockout cell line (HCT 116) | Human | PIGP | 1:2~1:4 | Negative | Online Inquiry |
KO22848 | PIGP Knockout cell line (HEK293) | Human | PIGP | 1:3~1:6 | Negative | Online Inquiry |
KO22849 | PIGP Knockout cell line (A549) | Human | PIGP | 1:3~1:4 | Negative | Online Inquiry |
PIGP Gene Knockout Cell Lines are sophisticated biological tools engineered for in-depth exploration of the PIGA gene's roles and functions in cellular processes. These cell lines are developed using CRISPR/Cas9 technology, resulting in precise mutations that render the PIGA gene inactive, thus facilitating the study of glycosylphosphatidylinositol (GPI) anchor synthesis and function in various biological contexts. By removing the gene’s expression, researchers can observe the downstream effects on cellular behavior, metabolic pathways, and interactions with the immune system.
The primary function of these knockout cell lines lies in their ability to serve as model organisms for studying GPI-anchored proteins, which play critical roles in cell signaling, adhesion, and immune responses. The absence of PIGA allows researchers to dissect the implications of GPI anchor deficiency, which is associated with various pathologies, including immunodeficiency, cancer, and other genetic disorders. Furthermore, these cell lines enable high-throughput screening and therapeutic development protocols, thus contributing to advancements in both fundamental and applied biomedical research.
What distinguishes the PIGP Gene Knockout Cell Lines from alternative models is their unparalleled specificity and reliability. They are validated through comprehensive genomic analysis, ensuring that researchers are working with a truly knockout model free from off-target effects. This fidelity enhances the reproducibility of experiments and the interpretability of results, making these cell lines an essential component for cutting-edge research in molecular biology and therapeutics.
For researchers and clinicians focused on genetic engineering, immunology, or cell biology, the PIGP Gene Knockout Cell Lines represent a unique opportunity to gain insights into the complexities of GPI anchoring and its implications for health and disease. Our company prides itself on its commitment to quality and innovation in the development of biological products, ensuring that our offerings are at the forefront of scientific research and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.